Ongororo Yakakwana YeGroundbreaking Leukemia Kurapa
Zviratidzo zveCAR-T
●B-cell acute lymphoblastic leukemia
●Multiple myeloma
●Chronic lymphocytic leukemia
●Non-Hodgkin lymphoma
●Kuparadzira hombe B-cell lymphoma
●SLE (Systemic Lupus Erythematosus)
●Myasthenia gravis
●Zvimwe zvirwere zve autoimmune
Yakanakisa CAR-T kiriniki yekuita
Zviratidzo zveCD19+20CAR-T:Varwere vane B-cell isiri Hodgkin's lymphoma
Mwedzi mumwe CR rate | Mwedzi mumwe PR rate | Mwedzi mumwe OR rate | CRS≥3 | CRES≥3 |
71.95% (59/82) | 25.6 (21/82) | 97.55 (80/82) | 12.19% (10/82) | 0 |
Zviratidzo zveCD19+22CAR-T:Kurapa kweCD19 kwakadzokororwa uye refractory acute B-lymphocytic leukemia varwere
Mwedzi mumwe CR rate | Mwedzi mumwe PR rate | Mwedzi mumwe OR rate | CRS≥3 | CRES≥3 |
92.1% (35/38) | 7.9% (3/38) | 100% (38/38) | 15.79% (6/38) | 0 |
Zviratidzo zveBCMACAR-T:Kurapa kwekudzokazve uye refractory multiple myeloma
Mwedzi mumwe CR rate | Mwedzi mumwe PR rate | Mwedzi mumwe OR rate | CRS≥3 | CRES≥3 |
72.41% (21/29) | 27.59% (8/29) | 100% (29/29) | 6.9% (2/29) | 0 |
Zvatiri Zvakanakira
● Personalized Treatment: Imwe neimwe yeCAR-T kurapa inogadziriswa kumurwere, kuve nechokwadi chakanyanya kunangwa uye inoshanda mhedzisiro yekurapa.
● Diverse Targeting Options: Nemhando dzakasiyana-siyana dzakanangwa maantigen, anosanganisira CD7, CD19, CD20, CD22, uye BCMA, zvigadzirwa zvedu zveCAR-T zvinopa kusarudzika kwakasiyana-siyana mukurapa kwakasiyana siyana hematological malignancies uye autoimmune zvirwere.
● Proven Clinical Success: Mishonga yedu yeCAR-T yakaratidza kushanda kwakasarudzika mumakesi mazhinji emakiriniki, nemitengo inoshamisa yekuregererwa uye nhoroondo dzekuchengetedza, kusimbisa chinzvimbo chedu semutungamiri mune immunotherapy.
● High Cost-Kubudirira: Isu tinopa mupendero wemakwikwi ane emhando yepamusoro marapirwo pamitengo inosvikika zvichienzaniswa nezvimwe zvigadzirwa zveCAR-T pamusika.
● Cutting-Edge Technology: Tichisimudzira kufambira mberi kwemajini enjiniya, kurapa kwedu kweCAR-T kunosanganisira ramangwana regomarara uye kurapwa kwechirwere che autoimmune.
● Nyanzvi Clinical Support: Chikwata chedu chine ruzivo revarapi nevatsvaguri vanopa hutano hwakakwana kubva pakutanga kubvunza kuburikidza nekurapa kwekutungamira uye kutevera.
Masero eCAR-T ave kuzivikanwa zvakanyanya nekuda kwekushanda kwawo muvarwere vasina kupindura kurapwa kwechinyakare senge chemotherapy kana bone marrow transplantation. Nharaunda yezvehutano yepasi rose inobvuma kugona kwepasi kweCAR-T kurapwa mukushandura mhedzisiro yevarwere.
tsananguro2